These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Investigating the relationship between anti-gp210 antibody and clinical basic profile of primary billiary cirrhosis]. Yang J, Yang JH, You LY, Xu ZY, Yang LH. Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):468-9. PubMed ID: 19567032 [No Abstract] [Full Text] [Related]
3. Characterization of autoantibodies against components of the nuclear pore complexes: high frequency of anti-p62 nucleoporin antibodies. Wesierska-Gadek J, Klima A, Komina O, Ranftler C, Invernizzi P, Penner E. Ann N Y Acad Sci; 2007 Aug; 1109():519-30. PubMed ID: 17785341 [Abstract] [Full Text] [Related]
7. Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis. Muratori P, Muratori L, Ferrari R, Cassani F, Bianchi G, Lenzi M, Rodrigo L, Linares A, Fuentes D, Bianchi FB. Am J Gastroenterol; 2003 Feb; 98(2):431-7. PubMed ID: 12591064 [Abstract] [Full Text] [Related]
8. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, Takii Y, Koyabu M, Yokoyama T, Migita K, Daikoku M, Abiru S, Yatsuhashi H, Takezaki E, Masaki N, Sugi K, Honda K, Adachi H, Nishi H, Watanabe Y, Nakamura Y, Shimada M, Komatsu T, Saito A, Saoshiro T, Harada H, Sodeyama T, Hayashi S, Masumoto A, Sando T, Yamamoto T, Sakai H, Kobayashi M, Muro T, Koga M, Shums Z, Norman GL, Ishibashi H. Hepatology; 2007 Jan; 45(1):118-27. PubMed ID: 17187436 [Abstract] [Full Text] [Related]
9. Diagnostic value of anti-gp210 antibodies in primary biliary cirrhosis: a case-based review. Valour F, Durupt S, Khenifer S, Durieu I. BMJ Case Rep; 2013 Jun 26; 2013():. PubMed ID: 23814122 [Abstract] [Full Text] [Related]
11. [Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis]. Romero Gómez M, Wichmann I, Otero Fernández MA, Suárez García E, Grande L, Núñez J, Nevado Santos M, Castro Fernández M. Gastroenterol Hepatol; 1999 Jan 26; 22(1):11-3. PubMed ID: 10089705 [Abstract] [Full Text] [Related]
12. Characterization of the antibodies to p62 nucleoporin in primary biliary cirrhosis using human recombinant antigen. Wesierska-Gadek J, Klima A, Ranftler C, Komina O, Hanover J, Invernizzi P, Penner E. J Cell Biochem; 2008 May 01; 104(1):27-37. PubMed ID: 17960595 [Abstract] [Full Text] [Related]
14. The value of antinuclear antibodies in primary biliary cirrhosis. Gao L, Tian X, Liu B, Zhang F. Clin Exp Med; 2008 Mar 01; 8(1):9-15. PubMed ID: 18385935 [Abstract] [Full Text] [Related]
16. Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients. Sfakianaki O, Koulentaki M, Tzardi M, Tsangaridou E, Theodoropoulos PA, Castanas E, Kouroumalis EA. World J Gastroenterol; 2010 Oct 21; 16(39):4938-43. PubMed ID: 20954280 [Abstract] [Full Text] [Related]